Market revenue in 2021 | USD 233.4 million |
Market revenue in 2028 | USD 294.5 million |
Growth rate | 3.4% (CAGR from 2021 to 2028) |
Largest segment | Pcr-based amplification |
Fastest growing segment | Nucleic Acid Sequence Based Amplification (NASBA) |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | PCR-based Amplification, Loop Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA), Strand Displacement Amplification (SDA), Multiple displacement amplification (MDA), Rolling Circle Amplification (RCA), Ramification amplification method (RAM) |
Key market players worldwide | Qiagen NV, Illumina Inc, Bio-Rad Laboratories Inc, Silicon Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, Danaher Corp, New England Biolabs, 4Basebio, LGC Group, Vazyme Biotech, MyBiosource |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene amplification technologies market will help companies and investors design strategic landscapes.
Pcr-based amplification was the largest segment with a revenue share of 90.62% in 2021. Horizon Databook has segmented the Brazil gene amplification technologies market based on pcr-based amplification, loop mediated isothermal amplification (lamp), nucleic acid sequence based amplification (nasba), strand displacement amplification (sda), multiple displacement amplification (mda), rolling circle amplification (rca), ramification amplification method (ram) covering the revenue growth of each sub-segment from 2018 to 2028.
In recent years, biopharmaceuticals have gained a significant share in the Brazilian pharmaceutical market. The favorable government initiatives coupled with investments for technological developments in private companies are anticipated to increase the adoption and use of gene delivery technologies in the country.
The growing field of genomics in the country is expected to increase the application of various gene amplification technologies in Brazil. For instance, in April 2019, Brazilian researchers estimated human immunodeficiency virus – 1 genetic diversity in Brazil.
This study used Nested PCR technology for amplification. Such research studies are anticipated to increase the market penetration of gene amplification technologies in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil gene amplification technologies market , including forecasts for subscribers. This country databook contains high-level insights into Brazil gene amplification technologies market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account